4-methylthiobenzoic acid

Several experimental parameters affecting surface enhanced Raman (SER) signals using 488, 785 and 1064 nm excitation for eight… (More)

The antitumor agent cisplatin has dose-limiting side effects such as ototoxicity. Systemical co-treatment with anti-oxidants like… (More)

4-Methylthioamphetamine (4-MTA) is a scheduled designer drug that has appeared on the illicit drug market and led to several non… (More)

Several cases of death associated with 4-methylthioamphetamine (4-MTA) have raised public concern about the abuse of this… (More)

HYPOTHESIS The goals of this investigation were to compare the efficacy of three protective agents against cisplatin-induced… (More)

The purpose of this study was to investigate the effectiveness of 4-methylthiobenzoic acid (MTBA) as a protection agent against… (More)

This study was undertaken in order to determine the changes in auditory brainstem-evoked responses relationship with the changes… (More)

HYPOTHESIS Cisplatin causes the generation of reactive oxygen species (ROS), which interferes with the antioxidant defense system… (More)

This study investigates the changes in renal antioxidant system after cisplatin administration and the nephroprotection with 4… (More)

Administration of 4-methylthiobenzoic acid (MTBA) (100 mg/kg) strongly reduced cisplatin nephrotoxicity (7.5 mg/kg, 20 min after… (More)